Raloxifene is an alternative ER modulator which was initially shown to mediate gene deletion without inducing transient cardiomyopathy [20], but as reported later by the same group resulted in an insufficiently consistent gene deletion in the same floxed mouse line as in their initial study [21]. Here, ESR1 is linked to cardiomyopathy.